EP1062319A4 - Facteur de croissance endothelial vasculaire 2 - Google Patents
Facteur de croissance endothelial vasculaire 2Info
- Publication number
- EP1062319A4 EP1062319A4 EP99912320A EP99912320A EP1062319A4 EP 1062319 A4 EP1062319 A4 EP 1062319A4 EP 99912320 A EP99912320 A EP 99912320A EP 99912320 A EP99912320 A EP 99912320A EP 1062319 A4 EP1062319 A4 EP 1062319A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- growth factor
- vascular endothelial
- endothelial growth
- vascular
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/042,105 US6040157A (en) | 1994-03-08 | 1998-03-13 | Vascular endothelial growth factor 2 |
US42105 | 1998-03-13 | ||
US09/107,997 US7186688B1 (en) | 1994-03-08 | 1998-06-30 | Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2 |
US107997 | 1998-06-30 | ||
PCT/US1999/005021 WO1999046364A1 (fr) | 1998-03-13 | 1999-03-10 | Facteur de croissance endothelial vasculaire 2 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1062319A1 EP1062319A1 (fr) | 2000-12-27 |
EP1062319A4 true EP1062319A4 (fr) | 2003-04-23 |
Family
ID=26718873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99912320A Withdrawn EP1062319A4 (fr) | 1998-03-13 | 1999-03-10 | Facteur de croissance endothelial vasculaire 2 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1062319A4 (fr) |
JP (1) | JP2002505873A (fr) |
KR (1) | KR20010034576A (fr) |
CN (1) | CN1299407A (fr) |
AU (1) | AU3072099A (fr) |
CA (1) | CA2322748A1 (fr) |
WO (1) | WO1999046364A1 (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7186688B1 (en) | 1994-03-08 | 2007-03-06 | Human Genome Sciences, Inc. | Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2 |
US6040157A (en) | 1994-03-08 | 2000-03-21 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
US7153827B1 (en) | 1994-03-08 | 2006-12-26 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 and methods of use |
US6734285B2 (en) | 1994-03-08 | 2004-05-11 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 proteins and compositions |
EP0751992B1 (fr) | 1994-03-08 | 2005-11-09 | Human Genome Sciences, Inc. | Facteur 2 de croissance endotheliale vasculaire |
US7109308B1 (en) | 1994-03-08 | 2006-09-19 | Human Genome Sciences, Inc. | Antibodies to human vascular endothelial growth factor 2 |
US6608182B1 (en) | 1994-03-08 | 2003-08-19 | Human Genome Sciences, Inc. | Human vascular endothelial growth factor 2 |
US5932540A (en) | 1994-03-08 | 1999-08-03 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
US6818220B1 (en) | 1994-11-14 | 2004-11-16 | Licentia Ltd. | Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof |
US6361946B1 (en) | 1997-02-05 | 2002-03-26 | Licentia Ltd | Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
US7423125B2 (en) | 1995-08-01 | 2008-09-09 | Vegenics Limited | Antibodies to VEGF-C |
CA2231400A1 (fr) | 1995-09-08 | 1997-03-13 | Genentech, Inc. | Proteine apparentee au vegf |
US7125714B2 (en) | 1997-02-05 | 2006-10-24 | Licentia Ltd. | Progenitor cell materials and methods |
ATE296117T1 (de) | 1997-03-07 | 2005-06-15 | Wistar Inst | Verwendung von adenoviralen vektoren, die pdgf oder vegf exprimieren, zur heilung von gewebsdefekten und zur induzierung der hypervaskulität in säugergeweben |
US6958147B1 (en) | 1998-10-26 | 2005-10-25 | Licentia Ltd | Use of VEGF-C to prevent restenosis |
US7223724B1 (en) | 1999-02-08 | 2007-05-29 | Human Genome Sciences, Inc. | Use of vascular endothelial growth factor to treat photoreceptor cells |
WO2000058511A1 (fr) | 1999-03-26 | 2000-10-05 | Ludwig Institute For Cancer Research | Dosage et therapie pour les troubles lymphatiques impliquant la tyrosine kinase flt4 (vegfr-3) |
US6764820B2 (en) | 1999-03-26 | 2004-07-20 | Ludwig Institute For Cancer Research | Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) |
DK1272208T3 (da) * | 2000-04-12 | 2011-10-31 | Vib Vzw | Anvendelse af VEGF 165 og homologer til at behandle neuron-sygdomme |
AU8473401A (en) * | 2000-08-04 | 2002-02-18 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
CA2431308C (fr) | 2000-12-07 | 2010-04-13 | Sangamo Biosciences, Inc. | Regulation de l'angiogenese au moyen de proteines a doigts de zinc |
US7067317B2 (en) | 2000-12-07 | 2006-06-27 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
KR20030093316A (ko) * | 2001-04-13 | 2003-12-06 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 혈관 내피 성장 인자 2 |
US7402312B2 (en) | 2001-04-13 | 2008-07-22 | Human Genome Sciences, Inc. | Antibodies to vascular endothelial growth factor 2 (VEGF-2) |
US7217570B2 (en) | 2001-08-23 | 2007-05-15 | The Wistar Institute Of Anatomy And Biology | Organotypic intestinal culture and methods of use thereof |
WO2003081201A2 (fr) * | 2002-03-21 | 2003-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Marqueurs de cellules sanguines peripheriques utiles pour le diagnostic de la sclerose en plaques et procedes et trousses comprenant de tels marqueurs |
ATE500842T1 (de) | 2002-05-04 | 2011-03-15 | Acorda Therapeutics Inc | Zusammensetzungen und verfahren zur förderung des neuronalen wachstums |
MX348062B (es) | 2003-05-16 | 2017-05-26 | Acorda Therapeutics Inc | Mutantes que degradan proteoglicanos para tratamiento del snc. |
US7959914B2 (en) | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
MXPA06013345A (es) | 2004-05-18 | 2008-10-31 | Acorda Therapeutics Inc | Metodos para purificar condrointinasa y sus formulaciones estables. |
RS51481B (en) | 2004-05-27 | 2011-04-30 | Vib, Vzw | TREATMENT OF AMIOTROPHIC LATERAL SCLEROSIS |
CA2599004C (fr) | 2005-02-28 | 2015-05-26 | Sangamo Biosciences, Inc. | Methodes et compostions anti-angiogeniques |
EP1928490B8 (fr) | 2005-09-26 | 2012-10-03 | Acorda Therapeutics, Inc. | Compositions et procedes d'utilisation de mutants des chondroitinases abci |
CN100448892C (zh) * | 2006-08-02 | 2009-01-07 | 中国人民解放军军事医学科学院基础医学研究所 | 抗肿瘤血管内皮生长因子受体vegf-r2抗原及其编码基因与应用 |
AU2007307736C1 (en) | 2006-10-10 | 2014-04-10 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase ABCI mutants |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995024473A1 (fr) * | 1994-03-08 | 1995-09-14 | Human Genome Sciences, Inc. | Facteur 2 de croissance endotheliale vasculaire |
WO1996039515A1 (fr) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Facteur de croissance endotheliale vasculaire 2 humain |
WO1997005250A2 (fr) * | 1995-08-01 | 1997-02-13 | Helsinki University Licensing Ltd. Oy | Facteur de croissance endothelial vasculaire (vegf-c) en tant que ligand de recepteur |
WO1997009427A1 (fr) * | 1995-09-08 | 1997-03-13 | Genentech, Inc. | Proteine apparentee au vegf |
WO1997017442A1 (fr) * | 1995-11-08 | 1997-05-15 | Immunex Corporation | Proteine de liaison flk-1 |
WO1998033917A1 (fr) * | 1994-11-14 | 1998-08-06 | The Ludwig Institute For Cancer Research | Proteine et gene du facteur de croissance vasculaire endothelial c (vegf-c), mutants de ce dernier et utilisations |
WO1998049300A2 (fr) * | 1997-04-25 | 1998-11-05 | Collateral Therapeutics | Formes tronquees de proteines apparentees au facteur vegf |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000029986A (ko) * | 1996-08-13 | 2000-05-25 | 벤슨 로버트 에이치. | 각질세포성장인자-2(케이쥐에프-2또는섬유아세포성장인자-12,에프쥐에프-12) |
-
1999
- 1999-03-10 JP JP2000535731A patent/JP2002505873A/ja active Pending
- 1999-03-10 KR KR1020007010016A patent/KR20010034576A/ko not_active Application Discontinuation
- 1999-03-10 EP EP99912320A patent/EP1062319A4/fr not_active Withdrawn
- 1999-03-10 CN CN99805771A patent/CN1299407A/zh active Pending
- 1999-03-10 AU AU30720/99A patent/AU3072099A/en not_active Abandoned
- 1999-03-10 CA CA002322748A patent/CA2322748A1/fr not_active Abandoned
- 1999-03-10 WO PCT/US1999/005021 patent/WO1999046364A1/fr not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995024473A1 (fr) * | 1994-03-08 | 1995-09-14 | Human Genome Sciences, Inc. | Facteur 2 de croissance endotheliale vasculaire |
WO1998033917A1 (fr) * | 1994-11-14 | 1998-08-06 | The Ludwig Institute For Cancer Research | Proteine et gene du facteur de croissance vasculaire endothelial c (vegf-c), mutants de ce dernier et utilisations |
WO1996039515A1 (fr) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Facteur de croissance endotheliale vasculaire 2 humain |
WO1997005250A2 (fr) * | 1995-08-01 | 1997-02-13 | Helsinki University Licensing Ltd. Oy | Facteur de croissance endothelial vasculaire (vegf-c) en tant que ligand de recepteur |
WO1997009427A1 (fr) * | 1995-09-08 | 1997-03-13 | Genentech, Inc. | Proteine apparentee au vegf |
WO1997017442A1 (fr) * | 1995-11-08 | 1997-05-15 | Immunex Corporation | Proteine de liaison flk-1 |
WO1998049300A2 (fr) * | 1997-04-25 | 1998-11-05 | Collateral Therapeutics | Formes tronquees de proteines apparentees au facteur vegf |
Non-Patent Citations (1)
Title |
---|
See also references of WO9946364A1 * |
Also Published As
Publication number | Publication date |
---|---|
KR20010034576A (ko) | 2001-04-25 |
CA2322748A1 (fr) | 1999-09-16 |
JP2002505873A (ja) | 2002-02-26 |
CN1299407A (zh) | 2001-06-13 |
WO1999046364A9 (fr) | 1999-11-18 |
WO1999046364A1 (fr) | 1999-09-16 |
AU3072099A (en) | 1999-09-27 |
EP1062319A1 (fr) | 2000-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1062319A4 (fr) | Facteur de croissance endothelial vasculaire 2 | |
EP1313512A4 (fr) | Facteur 2 de croissance endoth liale (vegf-2) | |
EP1385862A4 (fr) | Facteur de croissance endoth lial vasculaire 2 | |
AU5439998A (en) | Vascular endothelial growth factor | |
SG117417A1 (en) | Variants of the angiogenic factor vascular endothelial cell growth factor: vegf | |
WO2002083850A8 (fr) | Facteur 2 de croissance endotheliale vasculaire | |
AU5023300A (en) | Vascular endothelial growth factor variants | |
EP1137805A4 (fr) | Procedes destines a faciliter la croissance vasculaire | |
EP0873348A4 (fr) | Facteur de croissance 3 de l'endothelium vasculaire humain | |
EP0904292A4 (fr) | Facteur de differenciation en cours de croissance 14 | |
GB9722604D0 (en) | Heparin-binding growth factor derivatives | |
EP0550296A3 (en) | Vascular endothelial cells growth factor | |
AU5026100A (en) | Vascular endothelial growth factor dimers | |
EP0832215A4 (fr) | Facteur 11 de croissance des fibroblastes | |
EP0796325A4 (fr) | Facteur de croissance vasculaire humain proche de la proteine de fixation du facteur de croissance insulinoide | |
EP0832216A4 (fr) | Facteur 15 de croissance des fibroblastes | |
AU5440800A (en) | Fibroblast growth factor 10 | |
GB9828377D0 (en) | Vascular endothelial growth factor-e | |
AU5268000A (en) | Fibroblast growth factor 15 | |
AU4851200A (en) | Fibroblast growth factor 11 | |
AU3147799A (en) | Para-poxvirus-coded vascular endothelial cell growth factor (ppv-vegf) | |
GB9901323D0 (en) | Freeface 1 | |
EP0891372A4 (fr) | Facteur de croissance httr36 | |
AU5019700A (en) | Fibroblast growth factor 14 | |
AU6951400A (en) | Fibroblast growth factor 13 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000929 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030306 |
|
17Q | First examination report despatched |
Effective date: 20050608 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20051011 |